logo

For the Inventor, By the Inventor

Carlsbad, CA, United States of America

Ontogen Corporation


USPTO Granted Patents = 23

Forward Citations = 619

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Romaine R Maiefski (12 out of 18 patents)

silverMedal Adnan M Mjalli (10 out of 12 patents)

bronzeMedal Sepehr Sarshar (5 out of 34 patents)

4.  Don Wendell (5 out of 5 patents)

5.  Jonathan D Krakover (4 out of 4 patents)

6.  John Cargill (4 out of 9 patents)

7.  Xiaodong Cao (4 out of 6 patents)

8.  Farid Bakir (3 out of 15 patents)

9.  Chengzhi Zhang (3 out of 59 patents)

10.  Edmund J Moran (2 out of 48 patents)

11.  William Charles Ripka (2 out of 27 patents)

12.  Sepehar Sarshar (2 out of 2 patents)

13.  Thomas James Baiga (1 out of 2 patents)

14.  Robert W Armstrong (1 out of 3 patents)

15.  Todd Kevin Jones (1 out of 110 patents)


23 patents:

1. 6528324 - Apparatus for pre-determined mass sorting of positional-encoded solid phase synthesis supports (2003-03-04),
2. 6508938 - Apparatus and method for multiple channel high throughput purification (2003-01-21),
3. 6458273 - Sample separation apparatus and method for multiple channel high throughput purification (2002-10-01),
4. 6416718 - Sample wash station assembly (2002-07-09),
5. 6388076 - Protein tyrosine phosphatase-inhibiting compounds (2002-05-14),
6. 6358414 - Pressure regulation apparatus and method for multiple channel high throughput purification (2002-03-19),
7. 6358413 - Microsampling apparatus and method for multiple channel high throughout purification (2002-03-19),
8. 6355164 - Sample collection apparatus and method for multiple channel high throughput purification (2002-03-12),
9. 6309541 - Apparatus and method for multiple channel high throughput purification (2001-10-30),
10. 6171555 - Reaction block docking station (2001-01-09),
11. 6107274 - Piperazines as inhibitors of fructose-1,6-bisphosphatase (FBPase) (2000-08-22),
12. 5976470 - Sample wash station assembly (1999-11-02),
13. 5965558 - Modulators of proteins with phosphotyrosine recognition units (1999-10-12),
14. 5866569 - Naphthalenedione nitric oxide synthase (NOS) inhibitors (1999-02-02),
15. 5840721 - Imidazole derivatives as MDR modulators (1998-11-24),
Ontogen Corporation is a leading biotechnology company that focuses on developing innovative solutions to improve human health. With a strong emphasis on research and development, Ontogen Corporation is dedicated to discovering and commercializing groundbreaking therapies and treatments in various therapeutic areas, such as oncology, neurology, and infectious diseases. The company's mission is to make a positive impact on patients' lives by delivering advanced healthcare solutions. Visit our website to learn more about our pioneering work and the cutting-edge technologies we employ.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

23 Patents

#62 in Carlsbad, CA

#3,302 in California

#13,953 in US

#26,826 in the World

...
Carlsbad, CA, United States of America

Ontogen Corporation

Forward Citations = 619

19 inventors:

goldMedal Romaine R Maiefski (12 out of 18 patents)

silverMedal Adnan M Mjalli (10 out of 12 patents)

bronzeMedal Sepehr Sarshar (5 out of 34 patents)

4.  Don Wendell (5 out of 5 patents)

5.  Jonathan D Krakover (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com
Loading…